Category: CBSA News

CBSA advocates for policies that sustain innovation and create high-wage, high value jobs in life sciences, including strong intellectual property (IP) protections, which are the foundation of technol...

The mountains are calling at the 2024 Colorado BioScience Association Rocky Mountain Life Sciences Investor & Partnering Conference. By: Fitzsimons Innovation Community For the past 15 years, Elys...

Congress is grappling with a busy and complex agenda before adjourning on September 27 through the election. Congress is on track to meet its deadline of October 1 to pass a government funding measure...

The newly-announced “negotiated” prices for the first ten drugs subject to price controls under the Inflation Reduction Act (IRA) are set to go into effect for people with Medicare Part D prescription...

On August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) announced the new “negotiated” prices for the first ten Medicare Part D drugs subject to price controls under the Inflation R...

A partnership building bright futures. By: Fitzsimons Innovation Community In almost every sentence where Fitzsimons Innovation Community is mentioned, so too is our proximity to and partnership with...

CBSA advocates for policies that improve patient access to life-saving, novel technologies. This August, the Centers for Medicare & Medicaid Services (CMS) released the long-awaited Transitional C...

Presenting Companies Represent Transformative Technologies from the Rocky Mountain West DENVER, July 31, 2024 – Colorado BioScience Association (CBSA) highlights the momentum and opportunities in Colo...

Fitzsimons Innovation Community and so many more call this thriving community home. By: Fitzsimons Innovation Community If you ask the Economic Development team for Adams County Government what drives...

Patients say Upper Payment Limits (UPLs) won’t make their medicines more affordable. Colorado’s Prescription Drug Affordability Board (PDAB) hasn’t listened.   Colorado’s PDAB was created to...